logo

Xenon Pharmaceuticals Inc. (XENE)



Trade XENE now with
  Date
  Headline
5/15/2018 6:11:09 AM Xenon Presents Positive XEN1101 TMS Pharmacodynamic Phase 1 Data At 14th Eilat Conference
5/15/2018 6:05:44 AM Xenon Presents XEN901 Phase 1 Clinical Update And Supporting Pre-clinical Data At 14th Eilat Conference
3/28/2018 8:36:18 AM Xenon Confirms Closing Of Transaction With Teva And Announces Preferred Share Exchange Agreement With BVF Partners
3/13/2018 4:10:23 PM Xenon Pharmaceuticals Appoints Ernesto Aycardi As Chief Medical Officer
2/20/2018 8:43:23 AM Xenon Begins Phase 1 Clinical Trial Of Its Proprietary Epilepsy Product Candidate, XEN901
1/8/2018 8:39:46 AM Xenon Pharma Outlines Key Milestones For 2018